Mira Pharmaceuticals Inc (MIRA)

06:11 AM

Combining price and volume data for MIRA Pharmaceuticals Inc.Weekly Risk Report & Weekly Top Gainers Trade List - Newser

06:11 AM

02:49 AM

MIRA Pharmaceuticals Inc. stock trendline breakdownLong Setup & Daily Volume Surge Trade Alerts - Newser

02:49 AM

12:46 PM

Volume spikes in MIRA Pharmaceuticals Inc. stock – what they meanQuarterly Market Summary & Weekly Chart Analysis and Guides - Newser

12:46 PM

Aug 16, 2025

Analyzing drawdowns of MIRA Pharmaceuticals Inc. with statistical toolsQuarterly Portfolio Summary & Trade Opportunity Analysis - Newser

Aug 16, 2025

Aug 16, 2025

What’s the recovery path for long term holders of MIRA Pharmaceuticals Inc.2025 Price Action Summary & Weekly Stock Performance Updates - Newser

Aug 16, 2025

Aug 16, 2025

Visual trend scoring systems applied to MIRA Pharmaceuticals Inc.2025 Big Picture & Breakout Confirmation Trade Signals - Newser

Aug 16, 2025

Aug 16, 2025

Can MIRA Pharmaceuticals Inc. rally from current levels2025 Short Interest & Reliable Momentum Entry Alerts - Newser

Aug 16, 2025

Aug 16, 2025

Identifying reversal signals in MIRA Pharmaceuticals Inc.July 2025 Retail & Reliable Price Breakout Alerts - Newser

Aug 16, 2025

Aug 16, 2025

Is MIRA Pharmaceuticals Inc. exposed to currency risksJuly 2025 Reactions & Weekly Stock Performance Updates - newsyoung.net

Aug 16, 2025

Aug 16, 2025

Understanding MIRA Pharmaceuticals Inc.’s price movementJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser

Aug 16, 2025

Aug 16, 2025

What to expect from MIRA Pharmaceuticals Inc. in the next 30 days2025 Fundamental Recap & Precise Trade Entry Recommendations - Newser

Aug 16, 2025

Aug 16, 2025

How to build a custom watchlist for MIRA Pharmaceuticals Inc.Earnings Beat & High Accuracy Buy Signal Tips - Newser

Aug 16, 2025

Aug 16, 2025

How MIRA Pharmaceuticals Inc. stock performs during market volatilityPortfolio Risk Summary & Safe Entry Trade Signal Reports - Newser

Aug 16, 2025

Aug 16, 2025

How hedge fund analytics apply to MIRA Pharmaceuticals Inc. stockPortfolio Gains Summary & Safe Capital Growth Trade Ideas - Newser

Aug 16, 2025

Aug 16, 2025

Applying Elliott Wave Theory to MIRA Pharmaceuticals Inc.Quarterly Profit Summary & Consistent Growth Equity Picks - Newser

Aug 16, 2025

Aug 15, 2025

Mira Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 15, 2025

Aug 15, 2025

What makes MIRA Pharmaceuticals Inc. stock price move sharplyDollar Strength & Real-Time Market Sentiment Alerts - thegnnews.com

Aug 15, 2025

Aug 14, 2025

How moving averages guide MIRA Pharmaceuticals Inc. tradingShare Buyback & Real-Time Volume Spike Alerts - Newser

Aug 14, 2025

Aug 14, 2025

Is it too late to sell MIRA Pharmaceuticals Inc.2025 AllTime Highs & Smart Allocation Stock Tips - Newser

Aug 14, 2025

Aug 13, 2025

Forecasting MIRA Pharmaceuticals Inc. price range with options dataJuly 2025 Momentum & Risk Adjusted Swing Trade Ideas - Newser

Aug 13, 2025

Aug 13, 2025

Published on: 2025-08-13 06:59:24 - Newser

Aug 13, 2025

Aug 13, 2025

Published on: 2025-08-13 05:51:00 - Newser

Aug 13, 2025

Aug 12, 2025

MIRA Pharmaceuticals Announces Virtual Annual Meeting to Discuss SKNY Merger - MSN

Aug 12, 2025

Aug 12, 2025

Cannabinoid Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - GlobeNewswire Inc.

Aug 12, 2025

Aug 12, 2025

MIRA Pharmaceuticals’ Ketamir-2 Shows Promising Preclinical Results - TipRanks

Aug 12, 2025

Aug 12, 2025

MIRA Pharmaceuticals' Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin - ACCESS Newswire

Aug 12, 2025

Aug 12, 2025

Breakthrough: New Oral Pain Drug Shows Superior Results vs Ketamine, Targets $16.8B Market - Stock Titan

Aug 12, 2025

Aug 12, 2025

MIRA Pharmaceuticals’ Second Ketamir-2 Manuscript Accepted for Peer-Reviewed Publication Demonstrating Superior Efficacy in Preclinical Neuropathic Pain Models Versus Ketamine, Gabapentin, or Pregabalin - The Desert Sun

Aug 12, 2025

Aug 12, 2025

Ketamir-2 outperforms ketamine, plans Phase 2a FDA submission in Q4 2025 - Stock Titan

Aug 12, 2025

Aug 11, 2025

Published on: 2025-08-11 04:11:26 - Newser

Aug 11, 2025

Aug 10, 2025

MIRA Pharmaceuticals (MIRA) Projected to Post Quarterly Earnings on Tuesday - Defense World

Aug 10, 2025

Aug 09, 2025

Real time scanner hits for MIRA Pharmaceuticals Inc. explainedFree Alert Feed for Momentum Based Picks - Newser

Aug 09, 2025

Aug 06, 2025

What earnings revisions data tells us about Regulus Therapeutics Inc.Stock Price Prediction Using AI Tools - Newser

Aug 06, 2025

Aug 04, 2025

MIRA Pharmaceuticals Reports New Topical Ketamir-2 shows comparable effects to Injected Morphine in Preclinical Pain Study - The Florida Times-Union

Aug 04, 2025